A BLUEPRINT FOR SYNERGIES. IMPLEMENTING THE SPANISH GOVERNMENT’S PHARMACEUTICAL INDUSTRY STRATEGY
Tracks
AUDITORIUM MARGARITA SALAS
| Wednesday, October 8, 2025 |
| 9:30 - 10:15 |
| AUDITORIUM MARGARITA SALAS |
Overview
Sponsor: Amgen
Details
With input from the main industry associations, the Spanish Cabinet published in December 2024 its proposed Strategy Pharmaceutical Industry Strategy wich aims to address the health needs of the population as a driving force to develop an ecosystem of relationships in which innovation, production and access to medicines. The Strategy seeks to impact three key aspects of the pharmaceutical sector: equitable access to medicines, the sustainability of the NHS and the promotion of innovation and competitiveness of the industry. With these objectives, the Strategy promotes an ecosystem in which innovation, production, access to medicines and sustainability are integrated into the same approach. This roundtable convenes government officials and representatives of the industry to discuss how the strategy translates into a roadmap and identify concerns and challenges for the industry.
Details
AMGEN .
AMGEN
Sponsor
Mr Ion Arocena
Ceo
AseBio – Spanish Bioindustry Association
Moderator
Ms Fina Lladós
President
Farmaindustria
Speaker
Marina Pollán
General Director
Instituto de Salud Carlos III
Speaker
Mr Javier Padilla
Secretario De Estado De Sanidad
Secretario De Estado De Sanidad
Speaker